Burning Rock Biotech Limited (NASDAQ: BNR, the 'Company” or 'Burning Rock”), a company focusing on the application of next ...

However, the causative organism was not identified until 1992 by molecular methods and was initially named Tropheryma ...

The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...

Burning Rock Biotech (BNR) , a precision oncology company from China, has shown exceptional technical momentum and price ...

Key cancer diagnostics market opportunities include: early detection technologies like liquid biopsy and AI imaging, ...

The field of genomic medicine has experienced tremendous progress with the advent of next-generation sequencing (NGS), which ...

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...

This growth is primarily driven by the rising global cancer incidence, increasing preference for non-invasive diagnostic ...

Q4 2025 Earnings Call November 21, 2025 8:30 AM ESTCompany ParticipantsYvonne Perron - Vice President of Financial Planning ...

The global oncology biomarker market size is calculated at USD 38.62 billion in 2025 and is expected to reach around USD ...

Revenue generated from pharma research and development services was RMB42.0 million (US$5.9 million) for the three months ended September 30, 2025, representing a 68.6% increase from RMB24.9 million ...

The global forensic genomics market size was valued at US$ 0.5 Bn in 2024 and is projected to reach US$ 2.4 Bn by 2035, ...